Evaluation of a mouthrinse containing guava leaf extract as part of comprehensive oral care regimen- a randomized placebo-controlled clinical trial

Table 2 Description of clinical parameters among the test groups at different time intervals

Groups	Time intervals	N	Minimum	Maximum	Mean ± Std. Deviation
GINGIVAL INDEX
Group A	Baseline	20	1.10	2.64	1.86 ± 0.47
	1 month	18	.76	2.00	1.19 ± 0.34
	3 months	18	.20	1.45	.84 ± 0.34
Group B	Baseline	20	1.02	2.72	1.99 ± 0.47
	1 month	20	.57	2.10	1.29 ± 0.37
	3 months	20	.00	1.50	.62 ± 0.47
Group C	Baseline	20	1.32	2.72	2.21 ± 0.43
	1 month	19	.80	2.00	1.50 ± 0.40
	3 months	18	.70	1.50	1.23 ± 0.28
PLAQUE INDEX
Group A	Baseline	20	3.00	4.00	3.15 ± 0.36
	1 month	18	1	3	2.06 ± 0.53
	3 months	18	1	2	1.71 ± 0.47
Group B	Baseline	20	2.00	4.00	3.20 ± 0.52
	1 month	20	1	2	1.8 ± 0.41
	3 months	20	1	2	1.60 ± 0.50
Group C	Baseline	20	3.00	5.00	3.65 ± 0.67
	1 month	19	2	3	2.44 ± 0.51
	3 months	18	2	2	2.36 ± 0.02
COLONY FORMING UNIT (*10⁴)					MEDIAN
Group A	Baseline	20	2	710	135
	1 month	18	.09	250.00	10.5
	3 months	18	.01	200.00	9
Group B	Baseline	20	0	670	125
	1 month	20	.01	530.00	21
	3 months	20	.00	510.00	8.05
Group C	Baseline	20	24	550	180
	1 month	19	7.10	510.00	120
	3 months	18	8.10	520.00	150
ANTI-OXIDANT LEVELS					MEDIAN
Group A	Baseline	20	.01	.85	0.109
	1 month	18	.08	.93	0.1905
	3 months	18	.00	1.26	0.4705
Group B	Baseline	20	.00	.97	0.094
	1 month	20	.00	1.45	0.2025
	3 months	20	.00	1.85	0.4525
Group C	Baseline	20	.06	1.42	0.139
	1 month	19	.04	1.23	0.125
	3 months	18	.05	1.66	0.4385

ISSN: 2662-7671